Malignant fibrous histiocytoma overview: Difference between revisions
Varun Kumar (talk | contribs) |
Varun Kumar (talk | contribs) |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
'''Malignant fibrous histiocytoma''' (MFH) is a type of [[cancer]] that is the most common [[Sarcoma|soft tissue sarcoma]] of late adult life, most commonly occurring between age 50-70. In rare cases MFH does occur in children, but it is usually in a less aggressive form. However, malignant tumors have occurred in children as young as 13. It occurs more often in caucasians than those of African or Asian descent. Its male:female predominance is 2:1. | '''Malignant fibrous histiocytoma''' (MFH) is a type of [[cancer]] that is the most common [[Sarcoma|soft tissue sarcoma]] of late adult life, most commonly occurring between age 50-70. In rare cases MFH does occur in children, but it is usually in a less aggressive form. However, malignant tumors have occurred in children as young as 13. It occurs more often in caucasians than those of African or Asian descent. Its male:female predominance is 2:1. | ||
==Treatment== | |||
Treatment consists of surgical removal (the extent of which ranges from tumor excision to limb amputation depending on the tumor) and in some cases [[chemotherapy]]. | |||
==References== | ==References== |
Revision as of 22:07, 22 January 2012
Malignant fibrous histiocytoma Microchapters |
Differentiating Malignant Fibrous Histiocytoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Malignant fibrous histiocytoma overview On the Web |
American Roentgen Ray Society Images of Malignant fibrous histiocytoma overview |
Directions to Hospitals Treating Malignant fibrous histiocytoma |
Risk calculators and risk factors for Malignant fibrous histiocytoma overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Malignant fibrous histiocytoma (MFH) is a type of cancer that is the most common soft tissue sarcoma of late adult life, most commonly occurring between age 50-70. In rare cases MFH does occur in children, but it is usually in a less aggressive form. However, malignant tumors have occurred in children as young as 13. It occurs more often in caucasians than those of African or Asian descent. Its male:female predominance is 2:1.
Treatment
Treatment consists of surgical removal (the extent of which ranges from tumor excision to limb amputation depending on the tumor) and in some cases chemotherapy.